Shanghai Shen Lian Biomedical Corporation

SSE:688098.SS

5.99 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q12017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 78.74155.112121.92738.31888.05862.061116.35441.2281.85242.01148.32249.21389.0586.013119.38770.17482.85535.576147.53956.16998.44828.06795.35835.55294.83233.069109.31877.34577.34564.32864.32869.52469.524
Cost of Revenue 32.38424.06143.97518.25334.32221.14430.61213.63322.54411.54533.82512.5323.49627.331.68614.17513.82614.04419.1887.64214.224.30817.7445.55817.3445.956016.01916.01913.88213.88215.31115.311
Gross Profit 46.35731.05177.95120.06553.73640.91785.74227.58659.30730.465114.49836.68365.55358.71387.70155.99869.02921.531128.35148.52884.22823.75977.61429.99477.48827.113109.31861.32661.32650.44750.44754.21454.214
Gross Profit Ratio 0.5890.5630.6390.5240.610.6590.7370.6690.7250.7250.7720.7450.7360.6830.7350.7980.8330.6050.870.8640.8560.8470.8140.8440.8170.8210.7930.7930.7840.7840.780.78
Reseach & Development Expenses 11.111012.13512.97312.64714.26811.3810.1228.75712.64610.25210.9455.19717.0322.79910.2114.90410.4736.8247.6057.0098.5955.5356.7955.6394.27704.0464.0466.3116.3112.0622.062
General & Administrative Expenses 14.136032.848-4.22416.372-12.76928.031-3.15813.442-21.85641.667-5.36213.254-24.82840.781-6.09718.001-26.97517.194-5.67713.76-13.20712.726-1.6911.626-13.581013.78513.78514.88714.88713.44413.444
Selling & Marketing Expenses 22.085036.85827.88125.47423.80726.21815.9418.4219.82719.112.93921.2519.24512.88715.65115.59112.73920.34416.05414.85710.43217.10310.72320.6689.706018.9818.9816.35716.35715.115.1
SG&A 36.222-25.86169.70523.65741.84611.03854.24912.78231.862-2.02860.7677.57734.504-5.58353.6679.55433.592-14.23637.53810.37728.617-2.77529.8299.03332.294-3.875033.31533.31531.00331.00329.20929.209
Other Expenses 3.15182.859-21.806-0.264-0.007-69.138-0.3370.560.64228.161-18.49817.8260.517-1-1.401-0.3980.093-0.0230.0280.0052.5890.003-0.0210.001-0-0.023-61.254000000
Operating Expenses 50.48368.59860.03453.17155.25469.13852.02637.64941.26138.77852.5236.34740.21841.68331.96542.73838.57136.30942.49238.21336.2726.50834.30127.8638.37325.419-61.25429.87129.87130.7930.7929.00529.005
Operating Income -4.127-37.54817.917-33.385-3.495-7.07732.032-819.162-12.55259.9514.50528.67820.10658.49617.58432.499-9.51389.58215.29252.0330.94344.5064.53240.8766.7348.06327.48827.48818.81918.81924.4924.49
Operating Income Ratio -0.052-0.6810.147-0.871-0.04-0.1140.275-0.1940.234-0.2990.4040.0920.3220.2340.490.2510.392-0.2670.6070.2720.5290.0340.4670.1270.4310.2040.440.3550.3550.2930.2930.3520.352
Total Other Income Expenses Net -0.003-0.6880.029-0.264-0.007-0.025-0.3330.56-0.051-0.182-0.168-5.629-0.049-1-1.401-0.3980.093-0.0230.0280.0052.5890.003-0.0210-0-0.02304.5044.5041.0281.0280.4730.473
Income Before Tax -4.13-38.23617.946-33.648-3.502-7.10131.695-7.4419.111-12.73859.783-1.12428.6319.10757.09617.18632.592-9.53689.6115.29754.6220.94544.4844.53240.8766.70748.06331.99231.99219.84619.84625.63625.636
Income Before Tax Ratio -0.052-0.6940.147-0.878-0.04-0.1140.272-0.180.233-0.3030.403-0.0230.3220.2220.4780.2450.393-0.2680.6070.2720.5550.0340.4660.1270.4310.2030.440.4140.4140.3090.3090.3690.369
Income Tax Expense -0.075-6.508-1.47-0.338-0.377-0.4675.143-1.5043.244-1.35810.707-0.4744.7054.6979.6242.5944.606-1.47612.9341.6757.4930.126.3150.665.7850.7397.164.7994.7992.3542.3546.3936.393
Net Income -3.02-28.51520.383-32.299-2.209-5.60627.192-5.93515.868-11.3849.08-0.6523.92918.31147.4716.03728.384-7.91376.67613.62347.1290.82538.1693.87235.0915.96940.90327.19327.19317.49317.49319.24319.243
Net Income Ratio -0.038-0.5170.167-0.843-0.025-0.090.234-0.1440.194-0.2710.331-0.0130.2690.2130.3980.2290.343-0.2220.520.2430.4790.0290.40.1090.370.180.3740.3520.3520.2720.2720.2770.277
EPS -0.01-0.0760.05-0.079-0.007-0.0170.066-0.0150.039-0.0280.1-0.0010.050.0450.120.040.07-0.020.190.0350.120.0020.10.0110.10.0170.410.280.280.180.180.210.21
EPS Diluted -0.01-0.0760.05-0.079-0.007-0.0170.066-0.0150.039-0.0280.1-0.0010.050.0450.120.040.07-0.020.180.0350.120.0020.10.0110.10.0170.410.280.280.180.180.210.21
EBITDA -4.062-38.23125.929-32.11913.6288.92147.7288.24934.8092.35274.86312.32442.07629.8667.84728.30343.711-14.77796.16919.13454.6224.73648.2752.17942.0886.482109.31829.54529.54521.29221.29226.90726.907
EBITDA Ratio -0.052-0.6940.213-0.8380.1550.1440.410.20.4250.0560.5050.250.4720.3470.5680.4030.528-0.4150.6520.3410.5550.1690.5060.0610.4440.19610.3820.3820.3310.3310.3870.387